Robert Merrill Hunter - Net Worth and Insider Trading
Robert Merrill Hunter Net Worth
The estimated net worth of Robert Merrill Hunter is at least $29,664 dollars as of 2024-09-20. Robert Merrill Hunter is the 10% Owner of Cardiff Oncology Inc and owns about 11,725 shares of Cardiff Oncology Inc (CRDF) stock worth over $29,664. Details can be seen in Robert Merrill Hunter's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert Merrill Hunter has not made any transactions after 2012-04-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert Merrill Hunter
Robert Merrill Hunter Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert Merrill Hunter owns 2 companies in total, including Synergy Pharmaceuticals Inc (SGYPQ) , and Cardiff Oncology Inc (CRDF) .
Click here to see the complete history of Robert Merrill Hunter’s form 4 insider trades.
Insider Ownership Summary of Robert Merrill Hunter
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SGYPQ | Synergy Pharmaceuticals Inc | 2013-01-17 | 10 percent owner |
| CRDF | Cardiff Oncology Inc | 2012-04-13 | 10 percent owner |
Robert Merrill Hunter Latest Holdings Summary
Robert Merrill Hunter currently owns a total of 1 stock. Robert Merrill Hunter owns 11,725 shares of Cardiff Oncology Inc (CRDF) as of April 13, 2012, with a value of $29,664.
Latest Holdings of Robert Merrill Hunter
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRDF | Cardiff Oncology Inc | 2012-04-13 | 11,725 | 2.53 | 29,664 |
Holding Weightings of Robert Merrill Hunter
Robert Merrill Hunter Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert Merrill Hunter has made a total of 0 transactions in Cardiff Oncology Inc (CRDF) over the past 5 years. The most-recent trade in Cardiff Oncology Inc is the acquisition of 926 shares on April 13, 2012, which cost Robert Merrill Hunter around $200,000.
Insider Trading History of Robert Merrill Hunter
- 1
Robert Merrill Hunter Trading Performance
GuruFocus tracks the stock performance after each of Robert Merrill Hunter's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert Merrill Hunter is -16.67%. GuruFocus also compares Robert Merrill Hunter's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert Merrill Hunter within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Robert Merrill Hunter's insider trading performs compared to the benchmark.
Performance of Robert Merrill Hunter
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 24 | | | | | |
| Relative Return to S&P 500(%) | 25.23 | | | | | |
Robert Merrill Hunter Ownership Network
Robert Merrill Hunter Owned Company Details
What does Synergy Pharmaceuticals Inc do?
Who are the key executives at Synergy Pharmaceuticals Inc?
Robert Merrill Hunter is the 10 percent owner of Synergy Pharmaceuticals Inc. Other key executives at Synergy Pharmaceuticals Inc include director & Executive Chairman Gary S Jacob , Executive Vice Pres. & CFO Gary G Gemignani , and 10 percent owner Paulson & Co. Inc. .
Synergy Pharmaceuticals Inc (SGYPQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Synergy Pharmaceuticals Inc (SGYPQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Synergy Pharmaceuticals Inc (SGYPQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Synergy Pharmaceuticals Inc (SGYPQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Synergy Pharmaceuticals Inc Insider Transactions
Robert Merrill Hunter Mailing Address
Above is the net worth, insider trading, and ownership report for Robert Merrill Hunter. You might contact Robert Merrill Hunter via mailing address: C/o Callisto Pharmaceuticals, Inc., 420 Lexington Avenue, New York Ny 10170.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
